James Investment Research Inc. Boosts Stake in Cabot Corporation (CBT)

James Investment Research Inc. increased its position in Cabot Corporation (NYSE:CBT) by 417.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,242 shares of the specialty chemicals company’s stock after buying an additional 21,169 shares during the period. James Investment Research Inc.’s holdings in Cabot Corporation were worth $1,402,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Tower Research Capital LLC TRC raised its position in shares of Cabot Corporation by 344.9% in the first quarter. Tower Research Capital LLC TRC now owns 2,438 shares of the specialty chemicals company’s stock worth $146,000 after buying an additional 1,890 shares during the period. Integrated Investment Consultants LLC raised its position in shares of Cabot Corporation by 66.1% in the second quarter. Integrated Investment Consultants LLC now owns 3,097 shares of the specialty chemicals company’s stock worth $165,000 after buying an additional 1,233 shares during the period. Meeder Asset Management Inc. raised its position in shares of Cabot Corporation by 123.1% in the first quarter. Meeder Asset Management Inc. now owns 2,892 shares of the specialty chemicals company’s stock worth $173,000 after buying an additional 1,596 shares during the period. Timber Hill LLC bought a new position in shares of Cabot Corporation during the first quarter worth about $201,000. Finally, Oxford Asset Management bought a new position in shares of Cabot Corporation during the first quarter worth about $205,000. 85.42% of the stock is currently owned by institutional investors and hedge funds.

Cabot Corporation (CBT) opened at 54.51 on Friday. The firm has a market cap of $3.41 billion, a P/E ratio of 14.59 and a beta of 1.05. Cabot Corporation has a 12 month low of $46.88 and a 12 month high of $61.34. The company’s 50-day moving average is $53.46 and its 200 day moving average is $55.68.

Cabot Corporation (NYSE:CBT) last released its quarterly earnings data on Monday, May 1st. The specialty chemicals company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.02. Cabot Corporation had a return on equity of 16.83% and a net margin of 9.33%. The business had revenue of $678 million for the quarter, compared to analyst estimates of $637.57 million. During the same period last year, the firm posted $0.70 earnings per share. Cabot Corporation’s revenue was up 19.4% compared to the same quarter last year. Equities research analysts expect that Cabot Corporation will post $3.47 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Friday, August 25th will be paid a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date is Wednesday, August 23rd. Cabot Corporation’s payout ratio is 33.69%.

COPYRIGHT VIOLATION NOTICE: “[[title]]” was originally posted by [[site]] and is the property of of [[site]]. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at [[permalink]].

A number of equities analysts recently issued reports on CBT shares. SunTrust Banks, Inc. started coverage on shares of Cabot Corporation in a research report on Tuesday, April 18th. They set a “buy” rating and a $56.00 target price on the stock. Zacks Investment Research raised shares of Cabot Corporation from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, April 4th. Jefferies Group LLC reaffirmed a “buy” rating and set a $68.00 target price on shares of Cabot Corporation in a research report on Friday, March 24th. Northcoast Research raised shares of Cabot Corporation from a “neutral” rating to a “buy” rating and set a $63.00 target price on the stock in a research report on Wednesday, May 24th. Finally, BidaskClub raised shares of Cabot Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, July 6th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Cabot Corporation has a consensus rating of “Buy” and an average target price of $59.67.

About Cabot Corporation

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT).